Rchr
J-GLOBAL ID：202101016922686804
Update date: Jul. 02, 2024
Tanaka Tomohiro
タナカ トモヒロ | Tanaka Tomohiro
Affiliation and department：
Research field (2)：
Tumor biology
, Molecular biology
Research theme for competitive and other funds (2)：
- 2024 - 2026 Development of anti-chemokine receptor monoclonal antibody
- 2021 - 2023 Development of cancer specific monoclonal antibody
Papers (98)：
-
Rena Ubukata, Hiroyuki Suzuki, Tomohiro Tanaka, Guanjie Li, Mika K Kaneko, Yukinari Kato. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
-
Hiyori Kobayashi, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Epitope Mapping of an Anti-Mouse CCR8 Monoclonal Antibody C8Mab-2 Using Flow Cytometry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
-
Hiroyuki Suzuki, Tomohiro Tanaka, Guanjie Li, Tsunenori Ouchida, Mika K Kaneko, Yukinari Kato. Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
-
Hiroyuki Suzuki, Mayuki Tawara, Aoi Hirayama, Nohara Goto, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C44Mab-108) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. 43. 3. 85-89
-
Tsunenori Ouchida, Yu Isoda, Tomohiro Tanaka, Mika K. Kaneko, Hiroyuki Suzuki, Yukinari Kato. Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. 43. 3. 90-95
ｍore...
MISC (12)：
-
浅野 禎三, 李 冠傑, 鈴木 裕之, 田中 智大, 金子 美華, 加藤 幸成. CBIS法を用いた新規抗EpCAM抗体の樹立. 日本生化学会大会プログラム・講演要旨集. 2022. 95回. 1P-393
-
田中 智大, 大石 智一, 鈴木 裕之, 金子 美華, 川田 学, 加藤 幸成. 脱フコシル化キメラ抗EGFR抗体の犬がんモデルに対する抗腫瘍効果(Defucosylated mouse-dog chimeric anti-EGFR antibody exerts antitumor activity in canine cancer models). 日本癌学会総会記事. 2022. 81回. P-3047
-
鈴木 裕之, 後藤 のはら, 田中 智大, 金子 美華, 加藤 幸成. 食道がんを標的とした抗CD44モノクローナル抗体の開発(Development of a Novel Anti-CD44 Monoclonal Antibody for Esophageal Squamous Cell Carcinomas). 日本癌学会総会記事. 2022. 81回. P-1163
-
Saito Masaki, Tanaka Tomohiro, Asano Teizo, Suzuki Hiroyuki, K. Kaneko Mika, Kato Yukinari. Development of anti-mouse CC chemokine receptor 8 monoclonal antibody C8Mab-2. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 95. 1-P-095
-
Hiroyuki Suzuki, Li Guanjie, Asano Teizo, Tanaka Tomohiro, Kaneko Mika, Kato Yukinari. Antitumor Activities by a Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody in Canine Tumor Xenograft Models. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 96. 4-B-O12-5
ｍore...
Education (3)：
- - 2018 富山大学大学院 医学薬学教育部 博士後期課程 薬科学専攻
- - 2014 富山大学大学院 医学薬学教育部 博士前期課程 薬科学専攻
- - 2012 University of Toyama Faculty of Pharmacy and Pharmaceutical Sciences Pharmaceutical Sciences
Professional career (1)：
- Ph.D. (Pharmaceutical Science) (University of Toyama)
Work history (4)：
- 2024/04 - 現在 Tohoku University Graduate School of Medicine, Antibody Drug Development
- 2023/01 - 2024/03 Tohoku University
- 2021/01 - 2022/12 Tohoku University Graduate school of medicine, Antibody Drug Development
- 2018/04 - 2020/12 株式会社LSIメディエンス 試験研究センター 薬理研究部
Return to Previous Page
